ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NUS vs COR // EV/EBITDA & P/E VALUATION

Nu Skin Enterprises Inc. (NYSE) VS. Cencora Inc. (NYSE) • 15-METRIC TALLY: NUS 6 — COR 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NUS VS. COR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NUS COR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 69.40% 3.60% +65.80 NUS /gross-margins <GO>
Return on Invested Capital (ROIC) 6.70% 26.80% -20.10 COR /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 21.6x — TIE /valuation <GO>
Free Cash Flow Yield 20.15% 5.08% +15.07 NUS /fcf-yield <GO>
Operating Margin 4.40% 0.80% +3.60 NUS /operating-margins <GO>
Net Profit Margin 10.80% 0.50% +10.30 NUS /net-margins <GO>
Revenue Growth (YoY) -14.30% 9.30% -23.60 COR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 5.18% 0.69% +4.49 NUS /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.54 5.27 -1.73 COR /balance-sheet <GO>
Piotroski F-Score Quality 7/9 6/9 +1.00 NUS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.2 53.8 -8.60 COR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.88 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 37.8x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $228.3M $63.07B -$62.85B COR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NUS REV COR REV NUS GROSS % COR GROSS % NUS FCF COR FCF
FY 2025 $1.49B $321.33B 69.4% 3.6% $46.0M $3.21B
FY 2024 $1.73B $293.96B 68.2% 3.4% $70.2M $3.00B
FY 2023 $1.97B $262.17B — — $118.6M -$7.89B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NUS // BETA —
COR // BETA 0.88